Genenta Science (GNTA) director awarded stock options on 20,000 ADS

Rhea-AI Filing Summary

Genenta Science S.p.A. director Sharei Armon received a grant of stock options for 20,000 American Depositary Shares. The options have an exercise price of $0.63 per share and expire on December 31, 2035. They vest in equal monthly installments over one year beginning March 30, 2026.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Sharei Armon

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (right to buy)	20,000	$0.00	--

Holdings After Transaction: Stock Option (right to buy) — 20,000 shares (Direct)

Footnotes (1)

1. [object Object]

Key Figures

Option grant size: 20,000 options Exercise price: $0.63 per share Expiration date: December 31, 2035 +2 more

5 metrics

Option grant size 20,000 options Underlying 20,000 American Depositary Shares

Exercise price $0.63 per share Conversion or exercise price for the stock options

Expiration date December 31, 2035 Option term end date

Vesting schedule 12 monthly installments Vests over one year beginning March 30, 2026

Derivative holdings after grant 20,000 options Total stock options held following this transaction

Key Terms

Stock Option (right to buy), American Depositary Shares, exercise price, expiration date, +1 more

5 terms

Stock Option (right to buy) financial

"security_title: Stock Option (right to buy)"

American Depositary Shares financial

"underlying_security_title: American Depositary Shares"

American depositary shares (ADSs) are a way for investors in the United States to buy shares of foreign companies without dealing with international markets directly. They represent ownership in a foreign company's stock and are traded on U.S. stock exchanges, making it easier for American investors to buy, sell, and own parts of companies from around the world.

exercise price financial

"conversion_or_exercise_price: 0.6300"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

expiration date financial

"expiration_date: 2035-12-31T00:00:00.000Z"

The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.

vest in equal monthly installments financial

"The stock options vest in equal monthly installments over one year"

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sharei Armon

(Last) (First) (Middle)

27 BRUNSWICK ROAD

(Street)

ARLINGTON MASSACHUSETTS 02476

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Genenta Science S.p.A. [ GNTA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$0.63	03/30/2026		A		20,000		(1)	12/31/2035	American Depositary Shares	20,000	$0	20,000	D

Explanation of Responses:

1. The stock options vest in equal monthly installments over one year beginning March 30, 2026.

	/s/ Armon Sharei	04/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did GNTA director Sharei Armon report?

Director Sharei Armon reported receiving a grant of stock options for 20,000 underlying American Depositary Shares. These options are a form of equity compensation, giving the right to buy GNTA shares at a fixed exercise price in the future, subject to vesting.

What is the exercise price of the new GNTA stock options?

The granted stock options have an exercise price of $0.63 per share. This means Armon can choose to buy Genenta Science American Depositary Shares at $0.63, regardless of the market price at exercise, once the options have vested and before expiration.

How many GNTA shares are covered by the new stock option grant?

The stock option grant covers 20,000 underlying American Depositary Shares. This entire amount represents potential future share acquisitions if the options vest and are exercised, and it is also the total derivative position reported following the transaction.

When do Sharei Armon’s GNTA stock options vest and expire?

The options vest in equal monthly installments over one year, beginning March 30, 2026. They carry an expiration date of December 31, 2035, after which any unexercised options will lapse and can no longer be used to purchase shares.

Is this GNTA Form 4 transaction a market purchase or sale?

This Form 4 reflects a grant/award acquisition of stock options, not an open-market purchase or sale. The transaction code is A, meaning the options were granted as compensation, so no shares were bought or sold on the market in this event.